Research Article
Andreas G. Katopodis, Richard G. Warner, Rudolf O. Duthaler, Markus B. Streiff, Armin Bruelisauer, Olivier Kretz, Birgit Dorobek, Elke Persohn, Hendrik Andres, Alain Schweitzer, Gebhard Thoma, Willy Kinzy, Valerie F.J. Quesniaux, Emanuele Cozzi, Hugh F.S. Davies, Rafael Mañez, David White
Title and authors | Publication | Year |
---|---|---|
2025: status of cardiac xenotransplantation including preclinical models
Byrne GW, McGregor CG |
Frontiers in Transplantation | 2025 |
Differential Immune Response to Bioprosthetic Heart Valve Tissues in the α1,3Galactosyltransferase-Knockout Mouse Model.
Casós K, Llatjós R, Blasco-Lucas A, Kuguel SG, Sbraga F, Galli C, Padler-Karavani V, Le Tourneau T, Vadori M, Perota A, Roussel JC, Bottio T, Cozzi E, Soulillou JP, Galiñanes M, Máñez R, Costa C |
2023 | |
Removal of natural anti-αGal antibodies elicits protective immunity against Gram-negative bacterial infections.
Olivera-Ardid S, Bello-Gil D, Perez-Cruz M, Costa C, Camoez M, Dominguez MA, Ferrero-Alves Y, Vaquero JM, Khasbiullina N, Shilova NV, Bovin NV, Mañez R |
Frontiers in immunology | 2023 |
Exploring the relationship between Faecalibacterium duncaniae and Escherichia coli in inflammatory bowel disease (IBD): Insights and implications
Cabezas-Cruz A, Bermúdez-Humarán LG |
Computational and Structural Biotechnology Journal | 2023 |
Antibody-mediated rejection in xenotransplantation: Can it be prevented or reversed?
Habibabady Z, McGrath G, Kinoshita K, Maenaka A, Ikechukwu I, Elias GF, Zaletel T, Rosales I, Hara H, Pierson RN 3rd, Cooper DKC |
Xenotransplantation | 2023 |
Poly-L-Lysine-Based αGal-Glycoconjugates for Treating Anti-αGal IgE-Mediated Diseases.
Olivera-Ardid S, Bello-Gil D, Tuzikov A, Araujo RN, Ferrero-Alves Y, García Figueroa BE, Labrador-Horrillo M, García-Pérez AL, Bovin N, Mañez R |
Frontiers in immunology | 2022 |
Gut Microbiota Abrogates Anti-α-Gal IgA Response in Lungs and Protects against Experimental Aspergillus Infection in Poultry
L Mateos-Hernández, V Risco-Castillo, E Torres-Maravilla, LG Bermúdez-Humarán, P Alberdi, A Hodžić, A Hernández-Jarguin, S Rakotobe, C Galon, E Devillers, J de la Fuente, J Guillot, A Cabezas-Cruz |
Human vaccines | 2020 |
Selective in vivo removal of pathogenic anti-MAG autoantibodies, an antigen-specific treatment option for anti-MAG neuropathy
R Herrendorff, P Hänggi, H Pfister, F Yang, D Demeestere, F Hunziker, S Frey, N Schaeren-Wiemers, AJ Steck, B Ernst |
Proceedings of the National Academy of Sciences | 2017 |
Porcine to Human Heart Transplantation: Is Clinical Application Now Appropriate?
CG McGregor, GW Byrne |
Journal of Immunology Research | 2017 |
A pig-to-mouse coronary artery transplantation model for investigating the pathogenicity of anti-pig antibody
Y Lin, N Miyagi, GW Byrne, Z Du, H Kogelberg, MH Gazi, HD Tazelaar, C Wang, CG McGregor |
Xenotransplantation | 2015 |
Anti-non-Gal-specific combination treatment with an anti-idiotypic Ab and an inhibitory small molecule mitigates the xenoantibody response
JM Stewart, AF Tarantal, Y Chen, NC Appleby, TI Fuentes, CC Lee, EJ Salvaris, AJ d'Apice, PJ Cowan, M Kearns-Jonker |
Xenotransplantation | 2014 |
Immunological Challenges and Therapies in Xenotransplantation
M Vadori, E Cozzi |
Cold Spring Harbor Perspectives in Medicine | 2014 |
Identification of the tetraspanin CD82 as a new barrier to xenotransplantation
SM Saleh, RS Parhar, RS Al-Hejailan, RH Bakheet, HS Khaleel, HG Khalak, AS Halees, MZ Zaidi, BF Meyer, GP Yung, JD Seebach, W Conca, KS Khabar, KS Collison, FA Al-Mohanna |
Journal of immunology (Baltimore, Md. : 1950) | 2013 |
Infection barriers to successful xenotransplantation focusing on porcine endogenous retroviruses
J Denner, RR Tönjes |
Clinical microbiology reviews | 2012 |
Stem Cell Transplantation
C López-Larrea, A López-Vázquez, B Suárez-Álvarez |
2012 | |
Effect of hyperkalemia and hemolysis caused by hyperacute rejection on cardiac function in pig to human ex vivo xenogeneic cardiac perfusion model
JS Kim, HM Lee, BC Oh, HG Lim, JR Lee |
Korean Circulation Journal | 2011 |
Comparison of Gal and non-Gal-mediated cardiac xenograft rejection.
Tazelaar HD, Byrne GW, McGregor CG |
Transplantation | 2011 |
Barriers to the successful treatment of liver disease by hepatocyte transplantation
KA Soltys, A Soto-Gutiérrez, M Nagaya, KM Baskin, M Deutsch, R Ito, BL Shneider, R Squires, J Vockley, C Guha, J Roy-Chowdhury, SC Strom, JL Platt, IJ Fox |
Journal of Hepatology | 2010 |
Antibody-mediated xenograft injury: mechanisms and protective strategies
RN 3rd |
Transplant Immunology | 2009 |
Proteomic identification of non-Gal antibody targets after pig-to-primate cardiac xenotransplantation
GW Byrne, PG Stalboerger, E Davila, CJ Heppelmann, MH Gazi, HC McGregor, PT LaBreche, WR Davies, VP Rao, K Oi, HD Tazelaar, JS Logan, CG McGregor |
Xenotransplantation | 2008 |
Similarities in the immunoglobulin response and VH gene usage in rhesus monkeys and humans exposed to porcine hepatocytes
JL Zahorsky-Reeves, CR Gregory, DV Cramer, IY Patanwala, AE Kyles, DC Borie, MK Kearns-Jonker |
BMC Immunology | 2006 |